Head and neck soft tissue sarcomas: 40 Year casuistry from ENT Department of IPO-LFG

• Autor(a) principal: Fernandes Lopes, Patrícia
• Data de Publicação: 2023
• Outros Autores: Pedrosa, Gustavo Rocha, Trigueiros, António, Tinoco, Catarina, Montalvão, Pedro, Magalhães, Miguel
• Tipo de documento: Artigo
• Idioma: por; eng
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: https://doi.org/10.34631/sporl.2072
• topic: sarcomas; cabeça e pescoço; tumores; sarcomas; head and neck; tumors

Objective: To identify prognostic factors for Head and Neck Soft Tissue Sarcoma. Assess survival according to sublocation and treatment. Study design: Observational retrospective study Material/methods: Analysis of patients data with Head and Neck Soft Tissue Sarcoma followed at the ENT department at IPO-LFG between 1980 and 2022. Results: 59 patients (64% men) with a mean age of 47,2 years were selected. Chondrosarcoma and rhabdomyosarcoma were the most diagnosed and the larynx was the most affected local. 83% were operated; 28%% relapsed locally; and 10% had metastasis. 17% of patients died from the disease. The patients who received RT exclusively died. The disease-specific survival rate at the 5th year was 83%, with the spindle cell sarcoma having the worst results. Conclusion: Head and Neck Sarcomas have worse outcomes than other locations. Spindle cell sarcoma and primary treatment with RT were associated with higher mortality. Early surgical treatment is essential.